ArticleCancer science2014

Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.

Masakuni Serizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.